Vasospastic Angina: Clinical Trials

3 trials for Vasospastic Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 21Recruiting 1

Follow Vasospastic Angina: new trials by email Literature Review of Vasospastic Angina trials Research Report on Vasospastic Angina

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Amlodipine, Nebivolol, Placebo - Angina Pectoris, Microvascular Angina
Phase 2 / Phase 3RecruitingStanford University1502024-10-102024-11-27
Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
Cilostazol - Vasospastic Angina
Phase 3CompletedKorea Otsuka Pharmaceutical Co., Ltd.652013-12-012016-01-29
A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
Cilostazol, placebo - Vasospastic Angina
Phase 3CompletedKorea Otsuka Pharmaceutical Co., Ltd.1002013-11-012017-05-04

Narrower conditions

Angina Pectoris, Variant (3)  ·  Angina Pectoris (1)  ·  Microvascular Angina (1)

Broader conditions

Angina, Unstable (3)  ·  Cardiovascular Diseases (3)  ·  Chest Pain (3)  ·  Heart Diseases (3)  ·  Myocardial Ischemia (3)  ·  Neurologic Manifestations (3)  ·  Pain (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Angina Pectoris (2)

Interventions

Cilostazol (2)  ·  Amlodipine (1)  ·  Nebivolol (1)

Sponsors

Korea Otsuka Pharmaceutical Co., Ltd. (2)  ·  Stanford University (1)

Countries

South Korea (2)  ·  United States (1)

Top investigators

Jennifer Tremmel, MD (1)  ·  Junghong Kim, MD (1)